Physician profile
Basil Bernstein
NPI 1700971876
$3,080.99
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,602 · 2020: $482 · 2021: $635 · 2022: $278 · 2023: $83.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $534.43 | 2019-2021 | |
| Novo Nordisk INC | $478.99 | 2019-2022 | |
| Abbvie INC. | $401.79 | 2019-2023 | Vraylar, Lo Loestrin Fe |
| Allergan, INC. | $353.79 | 2019-2020 | |
| Antares Pharma, INC. | $150.99 | 2019-2021 | |
| Indivior INC. | $129.99 | 2019-2023 | Sublocade |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Amgen INC. | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $121.35 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.55 | 2019 | |
| Lilly USA, LLC | $83.67 | 2019 | |
| Scilex Pharmaceuticals INC. | $66.30 | 2019 | |
| Orexo US, INC. | $60.62 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.77 | 2019-2021 | |
| Almatica Pharma LLC | $34.44 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $34.30 | 2019-2020 | |
| Clarus Therapeutics INC. | $28.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.99 | 2021 | |
| Agile Therapeutics, INC. | $27.24 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $20.48 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.90 | 2019 | |
| Kaleo, INC. | $15.81 | 2019 | |
| Bausch Health US, LLC | $15.47 | 2022 | |
| Becton, Dickinson and Company | $15.33 | 2022 | |
| Hologic Sales and Service, LLC | $15.01 | 2019 | |
| Therapeuticsmd, INC. | $14.95 | 2021 | |
| Mission Pharmacal Company | $14.08 | 2020 | |
| Acerus Pharmaceuticals Corporation | $13.76 | 2021 | |
| Ironshore Pharmaceuticals INC. | $13.12 | 2019 | |
| Emergent Biosolutions INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.